Joseph A. Tyndall, Director at Axogen, Inc. (AXGN), sold 50,216 shares at $30.98 ($1.6M) on 2025-12-09, disclosed to the SEC on 2025-12-10.
Open-market sale of $1.6M AXGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.98 | 10,860 | $336K | 21.6% |
| 2 | $30.98 | 10,860 | $336K | 21.6% |
| 3 | $30.98 | 14,248 | $441K | 28.4% |
| 4 | $30.98 | 14,248 | $441K | 28.4% |
| Total | $30.98 avg | 50,216 | $1.6M | 100% |
| Filing → |
| AXGN | SELL | 2025-05-23 | $29K | — | Filing → |
| AXGN | SELL | 2025-05-23 | $305K | — | Filing → |